Preparations for signature of the protocol on cooperation between Rare Diseases Foundation of Iran and Imam Khomeini (RA) Relief Committee
President of the Islamic Republic of Iran honoured Dr. Hamid Reza Adraki, prominent member of the Rare Diseases Foundation of Iran
A protocol was signed between Rare Diseases Foundation of Iran and EURODIS on July 30th 2016
Arrival of EURODIS delegation in Tehran on July 25th 2016
According to the Department for Public Relations of the Rare Diseases Foundation of Iran, in order to find out about therapeutic and research achievements made by the Foundation, EURODIS delegation arrived in Iran on July 25th 2016. Explaining on this visit, Dr. Ali Davoudian, Managing Director of the Rare Diseases Foundation of Iran, stated that out of the major purposes behind the visit of the EURODIS delegation we need to refer to exchange views on different relevant issues as well as information and experiences of the two sides’ units that are rendering supportive and research services and to become familiarized with the achievements made by Iranian scientists in dealing with and treatment of rare diseases.
So far, 350 EB (Epidermolysis bullosa) patients have registered at the specialized health house for the group, said Seyyed Hamid Reza Hashemi Golpayegani, head of EB group at the Iranian Rare Disease Foundation (RADOIR). “The number is estimated to reach 500 by the end of the current Iranian year (March 20),” he said, IRNA reported.